Dr. Sandip Patel, MD
Claim this profileUC San Diego Moores Cancer Center
Expert in Lung Cancer
Expert in Cancer
25 reported clinical trials
46 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
EGFR negative
2Cancer
Global LeaderStage IV
Stage III
HLA-A positive
Affiliated Hospitals
Clinical Trials Sandip Patel, MD is currently running
FL115
for Cancer
First-in-Human, Phase I, open-label, multicenter, dose-escalation study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary antitumor activity of FL115 in patients with advanced solid tumors who have progressed or are intolerant to current standard-of-care therapies, including immune check-point inhibitors administered in single-agent or combination use.
Recruiting1 award Phase 112 criteria
SW-682
for Solid Tumors
This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed, during or after appropriate prior systemic anticancer therapy, including chemotherapy, immunotherapy, radiation therapy or targeted therapy, or for which no treatment is available, or prior standard of care (SOC) therapy was not tolerated and for which there is no further SOC treatment available. The study includes a Part 1 (Phase 1a) dose escalation phase and a Part 2 (Phase 1b) dose expansion to optimize the dose to be used for further development. All participants will self-administer SW-682 by mouth in 28-day cycles.
Recruiting1 award Phase 16 criteria
More about Sandip Patel, MD
Clinical Trial Related3 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Sandip Patel, MD has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- AZD2936
- Carboplatin
- Cisplatin
Breakdown of trials Sandip Patel, MD has run
Lung Cancer
Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandip Patel, MD specialize in?
Sandip Patel, MD focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Sandip Patel, MD currently recruiting for clinical trials?
Yes, Sandip Patel, MD is currently recruiting for 9 clinical trials in La Jolla California. If you're interested in participating, you should apply.
Are there any treatments that Sandip Patel, MD has studied deeply?
Yes, Sandip Patel, MD has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Sandip Patel, MD?
Apply for one of the trials that Sandip Patel, MD is conducting.
What is the office address of Sandip Patel, MD?
The office of Sandip Patel, MD is located at: UC San Diego Moores Cancer Center, La Jolla, California 92093 United States. This is the address for their practice at the UC San Diego Moores Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.